ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality of life"

  • Abstract Number: 1342 • ACR Convergence 2025

    The Impact of Age on Health-Related Quality of Life in Patients With Rheumatoid Arthritis Compared to Population Controls: A Cross-Sectional Analysis

    Saskia Truijen1, Annelies Boonen1, Sofia Ramiro2 and Marloes van Onna1, 1Maastricht University Medical Centre+ & Maastricht University, Maastricht, Limburg, Netherlands, 2Leiden University Medical Center, Bunde, Netherlands

    Background/Purpose: As the population ages, rheumatologists will increasingly care for older persons with rheumatoid arthritis (RA). Aging comes with specific challenges of which rheumatologists are…
  • Abstract Number: 1079 • ACR Convergence 2025

    Sociodemographic, Clinical, and Community-Level Deprivation Factors are Associated with Health-Related Quality of Life in Systemic Sclerosis

    Sarah Smith1, Paula Ramos2, Dulaney Wilson3, Diane Kamen4 and Richard Silver1, 1Medical University of South Carolina, Charleston, SC, 2Emory University School of Medicine, Atlanta, GA, 3Medical University of South Carolina, Charleston, 4Medical University of South Carolina, Johns Island, SC

    Background/Purpose: Systemic sclerosis (SSc) is a multisystem autoimmune disease with heterogeneous manifestations and significant impairment in health-related quality of life (HRQoL). SSc outcomes are shaped…
  • Abstract Number: 0314 • ACR Convergence 2025

    What changes in quality of life can be observed in patients with knee or hip OA prior to total hip or total knee replacement surgery ? data from the KHOALA cohort

    Anne-Christine Rat1, LATOURTE Augustin2, Maud Wieczorek3, Jérémie sellam4, willy Ngueyon Sime5, Jacques Pouchot6, Christian Roux7, Alain SARAUX8, Francis Guillemin9 and Joel Coste10, 1Caen University hospital, UMR 1075 Caen normandy university, Caen, France, 2Rheumatology Department, Lariboisiere Hospital, Paris, France, 3Lausanne Univserty, Lausanne, Switzerland, 4Saint-Antoine hospital, Assistance Publique – Hôpitaux de Paris, Paris, France, Sorbonne University, Paris, France, 5CIC, Epidémiologie Clinique, CHRU-Nancy, Inserm, Université de Lorraine, Nancy, France, nNancy, France, 6HEGP hospital, Assistance Publique-Hopitaux de Paris,, Paris, France, 7CHU Nice, Nice, France, 8CHU Brest, Brest, France, 9CHU Nancy, Nancy, France, 10, Assistance Publique – Hôpitaux de Paris, Paris, France

    Background/Purpose: Few studies have examined how the quality of life (QoL) evolves in patients with osteoarthritis (OA) before undergoing total hip or total knee replacement…
  • Abstract Number: 2553 • ACR Convergence 2025

    Impact of Polypharmacy on Treatment Adherence and Its Effect on The Quality of Life in Patients with Rheumatic Diseases

    Egla Samantha Sanchez-Peralta1, Margarita Isabel Alarcon-Jarquin2, Vanessa L. Lopez-Flores2, Dionicio A. Galarza-Delgado3 and Diana E. Flores-Alvarado1, 1Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, México, Monterrey, Nuevo Leon, Mexico, 2Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 3Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: Treatment adherence is fundamental for adequate control of rheumatic diseases. Nevertheless, due to the chronic nature of these conditions, polypharmacy can impact treatment adherence,…
  • Abstract Number: 2065 • ACR Convergence 2025

    Pain in Idiopathic Inflammatory Myopathies: A Global Study of Patient Experience

    Lekshmi Minikumari Rahulan1, Shounak Ghosh2, Manali Sarkar3, Didem Saygin4, Karin Lodin5, Rima Shrestha6, Tulika Chatterjee7, Jessica Day8, Samuel Shinjo9, Sreoshy Saha10, Lorenzo Cavagna11, Masataka Kuwana12, Vikas Agarwal13 and Latika Gupta14, 1Sanjay Gandhi Postgraduate Institute of Medical sciences Lucknow, Lucknow, Uttar Pradesh, India, 2Department of Rheumatology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK, Wolverhampton, United Kingdom, 3Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, Maharashtra, India., Mumbai, Maharashtra, India, 4Rush University Medical Center, Chicago, IL, 5Department of Gastro, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden, Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, 6Department of Internal Medicine, University of Illinois College of Medicine Peoria, Illinois, United States, Department of Research Services, University of Illinois College of Medicine Peoria, Illinois, United States, Illinois, 7Department of Internal Medicine, University of Illinois College of Medicine Peoria, Illinois, United States, Illinois, 8Walter and Eliza Hall Institute, Melbourne, Victoria, Australia, 9Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, Sao Paulo, Brazil, 10Mymensingh Medical College, Mymensingh, Bangladesh, Mymensingh, Bangladesh, 11Associate Professor in Rheumatology (Internal Medicine and Thepaeutics),University of Pavia, Pavia, Lombardy, Italy, Physician in Chief of Myositis Outpatients Clinic,Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia,Italy, Lombardia, Italy, 12Nippon Medical School Graduate School of Medicine, Tokyo, Japan, 13Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 14School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham; Royal Wolverhampton NHS Trust; Centre for Musculoskeletal Research, School of Biological Sciences, The University of Manchester, Manchester; Francis Crick Institute, London, Birmingham, UK, United Kingdom

    Background/Purpose: Pain remains a significant yet understudied aspect of idiopathic inflammatory myopathies (IIMs), considerably reducing quality of life despite advancements in immunomodulatory therapies. Information obtained…
  • Abstract Number: 1327 • ACR Convergence 2025

    Systematic Review of Mobility in Rheumatoid Arthritis with Digitally Measured Objective Assessment

    Anna fishbein1, Rachel Lawson2, Veleka Allen1, Xiaozhong Zhang3, Laura Chambre4, Stephen Ruhmel1, Sophie Wilhelm1, Fredric Marrache5, Maria Wiekowski1, Markus Kohlmann6 and Jeffrey Curtis7, 1Sanofi, Morristown, NJ, 2Sanofi, Earley, United Kingdom, 3Sanofi, Chengdu, China (People's Republic), 4Sanofi, Cambridge, MA, 5Sanofi, Gentilly, France, 6Sanofi, Frankfurt, Germany, 7University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Patients with rheumatoid arthritis (RA) are less physically active than the general population, and these activity differences can be measured through digital devices. This…
  • Abstract Number: 1022 • ACR Convergence 2025

    Abuse in Rheumatic Diseases: Associations with Depression, Disability, and Psychosocial Risk Factors

    Margarita Isabel Alarcon-Jarquin1, Egla Samantha Sanchez-Peralta2, Maria Eugenia Corral-Trujillo3, Daniela Alejandra Salcedo-Soto4, Judith Michelle Ramirez-Alonso4, Ana Elena González-Rosales5, Juan Daniel Valdez-Cruz4, Osmel Adrián Ramirez-Uzcategui4, Jesús Gilberto Espinoza-Gámez6, Yessica Rubi Reyes-Yepiz14, Juan Pablo González-Morales4, Virginia Pascual-Ramos7, Dionicio A. Galarza-Delgado8, Gabriel Figueroa-Parra9 and Diana E. Flores-Alvarado2, 1Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, México, Monterrey, Nuevo Leon, Mexico, 3Universidad Autónoma de Nuevo León, Rheumatology Service, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo León, México., Monterrey, Nuevo Leon, Mexico, 4Hospital universitario José Eleuterio González, Monterrey, Nuevo Leon, Mexico, 5Hospital universitario José Eleuterio González, Monterrey, Mexico, 6Rheumatology Service, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo Leon, Mexico, 7Rheumatology Service, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico, Mexico City, Distrito Federal, Mexico, 8Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 9Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico

    Background/Purpose: Exposure to a hostile environment may negatively impact disease outcomes in patients with RD, particularly by affecting their mental health and overall quality of…
  • Abstract Number: 0282 • ACR Convergence 2025

    Clinical Meaningfulness and Improvement Thresholds of Myositis Core Set Measures: Association with Patient-Reported Outcomes

    Shiri Keret1, Raisa Lomanto Silva2, Irada Choudhuri3, Eugenia Gkiaouraki3, Tanya Chandra3, Nantakarn Pongtarakulpanit3, Shreya Sriram3, Niladri Bhowmick3, Vaidehi Kothari3, Kaushik Sreerama Reddy3, Eaman Alhassan4, Anushka Aggarwal5, Maha Almackenzie6, Siamak Moghadam-Kia4, Dana Ascherman7, Chester V. Oddis7 and Rohit Aggarwal8, 1Bnai Zion Medical Center, Atlit, Israel, 2Massachusetts General Hospital, Boston, MA, 3University of Pittsburgh Medical Center, Pittsburgh, 4University of Pittsburgh Medical Center, Pittsburgh, PA, 5Indraprastha Apollo Hospital, New Delhi, India, 6Medical Cities of the Ministry of the Interior, Riyadh, Saudi Arabia, 7University of Pittsburgh, Pittsburgh, PA, 8University of Pittsburgh, Rheumatology and Clinical Immunology, Pittsburgh, United States of America, Pittsburgh, PA

    Background/Purpose: The six myositis core set measures (CSMs) are widely utilized to assess disease activity in idiopathic inflammatory myopathies (IIM). However, their association with how…
  • Abstract Number: 2548 • ACR Convergence 2025

    Management of Uncontrolled Gout Among Rheumatologists: Findings from a Medical Chart Audit

    Hyon K. Choi1, Nana Kragh2, Amod Athavale3, Bhavisha Desai4, Amal Gulaid3, Abiola Oladapo5, Brittany Smith3 and Kenneth Saag6, 1MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA, 2Sobi, Kongens Lyngby, Denmark, 3Trinity Life Sciences, Waltham, MA, 4Sobi, Glastonbury, CT, 5Sobi INC, Waltham, MA, 6The University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Uncontrolled gout (UG) is defined by  persistently high sUA levels, despite the use of oral urate lowering treatments (ULT), resulting in gout-related manifestations. Current…
  • Abstract Number: 1919 • ACR Convergence 2025

    Financial insecurity and discrimination are associated with patient-reported quality of life in patients with SLE

    Heather Gold1, Yi Li1, Peter Izmirly2, Jill Buyon1, Mala Masson3, Amit Saxena1, H Michael Belmont4, Chung-E Tseng5 and Rebecca Anthopolos1, 1NYU Grossman School of Medicine, New York, NY, 2New York University Grossman School of Medicine, New York, NY, 3NYU Langone Health, New York, 4NYU School of Medicine, New York, NY, 5New York University Grossman School of Medicine, Flushing, NY

    Background/Purpose: Manifestations of SLE are known to affect patient-reported outcome measures (PROs) such as physical function, fatigue, and pain. Other work has suggested economic insecurity…
  • Abstract Number: 1324 • ACR Convergence 2025

    Similar Negative Effects of Fatigue on Physical Activity in Persons with Rheumatoid Arthritis and Healthy Controls: A Patient-Control Study

    Maartje Cox1, Kyra Theunissen2, Kenneth Meijer2, Annick Timmermans3, Sofia Ramiro4, Annelies Boonen5 and Guy Plasqui2, 1Australian National Phenome Centre - Murdoch University, Booragoon, Western Australia, Australia, 2Maastricht University, Maastricht, Netherlands, 3Universiteit Hasselt, Hasselt, 4Leiden University Medical Center, Bunde, Netherlands, 5Maastricht University Medical Centre+ & Maastricht University, Maastricht, Limburg, Netherlands

    Background/Purpose: People with rheumatoid arthritis (pwRA) are prone to fall short of the World Health Organization’s physical activity (PA) recommendations due to perceived fatigue and…
  • Abstract Number: 0676 • ACR Convergence 2025

    Engineered glove for the objective assessment of hand dexterity in patients with systemic sclerosis: correlations with clinical features, nailfold videocapillaroscopy, and high frequency skin ultrasonography

    Alberto Sulli1, Elvis Hysa2, Paolo Clini3, Emanuele Gotelli4, Tamara Vojinovic5, Carmen Pizzorni1, Ali Jaffal3, Sabrina Paolino1, Rosanna Campitiello3, Vanessa Smith6 and Maurizio Cutolo3, 1University of Genoa, Genova, Italy, 2University of Genoa, Genoa, Italy, 3University of Genova, Genova, Italy, 4University of Genoa, Genoa, Liguria, Italy, 5University of Genoa, Genova, 6Ghent University Hospital, Gent, Belgium

    Background/Purpose: Hand disability is a major feature of systemic sclerosis (SSc), driven by skin thickening and joint contractures, with significant impact on quality of life.…
  • Abstract Number: 0083 • ACR Convergence 2025

    Confirmatory Factor Analysis of the Plutchik Suicide Risk Scale in Patients with Rheumatoid Arthritis

    Pedro Quevedo1, Javier mora2, william garcia2, alejandra Solano2, juliana Muñoz2 and Daniela Lopez2, 1San Rafael Cinic University Hospital, Bogota, Distrito Capital de Bogota, Colombia, 2san rafael clinic universtity hospital, Bogota, Distrito Capital de Bogota, Colombia

    Background/Purpose: Prevalence of depression in RA patients ranging from 10% to 25%, making it the most common psychiatric disorder in this population. The Plutchik Suicide…
  • Abstract Number: 2539 • ACR Convergence 2025

    Patient-reported outcomes in patients with polymyalgia rheumatica under rheumatology care: baseline data from the ENRICH-PMR cohort

    Sebastian E Sattui1, Amy Mudano2, Yujie Su2, Sandeep Sodhi3, Fenglong Xie4, Iris Navarro-Millan5, Robyn Domsic6 and Jeffrey Curtis7, 1Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 2Foundation for Advancing Science, Technology, Education and Research (FASTER), Hoover, AL, 3Illumination Health, Hoover, AL, 4The University of Alabama at Birmingham, Birmingham, AL, 5Weill Cornell Medicine, Hospital for Special Surgery, Poughkeepsie, NY, 6University of Pittsburgh, Pittsburgh, PA, 7University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Worse health-related quality of life has been reported in individuals with polymyalgia rheumatica (PMR), yet the factors contributing to this burden – including the…
  • Abstract Number: 1660 • ACR Convergence 2025

    Digital Psychological Support for Inflammatory Rheumatic Diseases: A Randomized Clinical Trial

    Johannes Knitza1, Julia Kraus2, Martin Krusche3, Isabell Haase3, Philipp Klemm4, Axel Hueber5, Pfeil Alexander6, Ulrich Drott7, Sebastian Kuhn8 and Jan Philipp Klein9, 1Institute for Digital Medicine, University Hospital Gießen-Marburg, Philipps University, Marburg, Germany, 2Vila Health, Berlin, Germany, 3Division of Rheumatology and Systemic Inflammatory Diseases, III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 4Department of Rheumatology and Clinical Immunology Center, JLU Giessen, Campus Kerckhoff, Bad Nauheim, Germany, Bad Nauheim, Germany, 5Klinikum Nuernberg, Nuernberg, Germany, 6Department of Internal Medicine III, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany, 7Deutsches Endokrinologisches Versorgungszentrum, Frankfurt, Germany, 8Institute for Digital Medicine, University Hospital of Giessen and Marburg, Philipps University Marburg, Marburg, Germany, 9Department of Psychiatry, Psychosomatics and Psychotherapy, University of Lübeck, Lübeck, Germany

    Background/Purpose: Patients with inflammatory rheumatic diseases (IRDs) frequently experience psychological distress, however access to psychological support remains limited. The aim of this trial (DRKS identifier:…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 30
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology